Tubulis to Present Phase I/IIa Trial Data for ADC Candidate tub-040 in Platinum-resistant Ovarian Cancer in Rapid Oral Presentation at ASCO 2026 Business Wire (Press Release) 15:12 Tue, 21 Apr
Gilead acquires FMP and LMU Spin-off Tubulis and expands Oncology Pipeline with next-generation ADC Forschungsverbund Berlin e.V. 07:00 Thu, 09 Apr
Stat Plus: AIDS group sues Trump administration over undisclosed agreement with Gilead STAT 2d AIDS Pharma Biotech
Gilead Sciences (GILD) declines more than market: Some information for investors Zacks 00:01 Tue, 21 Apr S&P 500 Pharma Stock Market
Graves of two missing Lance Corporals from World War One identified in Belgium GOV.UK (Press Release) 1d Worthing West Sussex Surrey
Ghent’s Club Wintercircus opens with L-Acoustics L-ISA immersive audio MONDO-DR 2d Technology (UK) Savings
When promising cures collapse before they reach patients Newswise (Press Release) 1h Coronavirus Vaccine Pfizer BioNTech
Renibus therapeutics announces Oral Presentation on Phase 3 protect trial data for rbt-1 at the American Association for thoracic surgery (aats) Annual Meeting PR Newswire (Press Release) 2h Biotechnology
State-of-the-art facility at biotech campus to help reinforce UK’s biosecurity TheBusinessDesk.com 5h Pharma York Biotechnology Article paywall
Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years FiercePharma 1d Pharma Regeneron
4 Sleep problems that neurologists say might actually be your brain sending warning signals about dementia BuzzFeed 10h
